标题
Chronic lymphocytic leukaemia
作者
关键词
-
出版物
Nature Reviews Disease Primers
Volume 3, Issue -, Pages 16096
出版商
Springer Nature
发表日期
2017-01-18
DOI
10.1038/nrdp.2016.96
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- P-048Prognostic Impact of CA19-9 Level at Diagnosis in Resected Stage I-III Pancreatic Adenocarcinoma: a US Population Study
- (2016) K. Mirkin et al. ANNALS OF ONCOLOGY
- IL-4 enhances expression and function of surface IgM in CLL cells
- (2016) M. M. Aguilar-Hernandez et al. BLOOD
- High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia
- (2016) B. Cui et al. BLOOD
- Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
- (2016) B. L. Lampson et al. BLOOD
- Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia
- (2016) Joseph A. Fraietta et al. BLOOD
- The Dohner fluorescencein situhybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience
- (2016) Daniel L. Van Dyke et al. BRITISH JOURNAL OF HAEMATOLOGY
- A high rate of telomeric sister chromatid exchange occurs in chronic lymphocytic leukaemia B-cells
- (2016) Sandrine Medves et al. BRITISH JOURNAL OF HAEMATOLOGY
- Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic Leukemia
- (2016) J. Ojha et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics
- (2016) C. Vitale et al. CLINICAL CANCER RESEARCH
- Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemia
- (2016) Giuseppe Spadaro et al. CLINICAL IMMUNOLOGY
- Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2
- (2016) Sujata Bhoi et al. Epigenetics
- Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials
- (2016) Massimo Gentile et al. EUROPEAN JOURNAL OF CANCER
- Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells
- (2016) Andrew Getahun et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Second-generation inhibitors of Bruton tyrosine kinase
- (2016) Jingjing Wu et al. Journal of Hematology & Oncology
- An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data
- (2016) LANCET ONCOLOGY
- First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial
- (2016) Barbara Eichhorst et al. LANCET ONCOLOGY
- Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
- (2016) Stephan Stilgenbauer et al. LANCET ONCOLOGY
- Effect of first-line treatment on second primary malignancies and Richter’s transformation in patients with CLL
- (2016) C Maurer et al. LEUKEMIA
- Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia
- (2016) Julio C. Chavez et al. LEUKEMIA RESEARCH
- Ionizing radiation exposures in treatments of solid neoplasms are not associated with subsequent increased risks of chronic lymphocytic leukemia
- (2016) Tomas Radivoyevitch et al. LEUKEMIA RESEARCH
- DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia
- (2016) Christopher C Oakes et al. NATURE GENETICS
- Driving CAR T-cells forward
- (2016) Hollie J. Jackson et al. Nature Reviews Clinical Oncology
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
- (2016) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epstein-Barr virus-positive diffuse large B cell lymphoma arising from a chronic lymphocytic leukemia: Overlapping features with classical Hodgkin lymphoma
- (2016) Yun-An Chen et al. PATHOLOGY INTERNATIONAL
- Richter syndrome: pathogenesis and management
- (2016) Davide Rossi et al. SEMINARS IN ONCOLOGY
- Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
- (2016) Jan A. Burger et al. Nature Communications
- Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia
- (2016) Sonja I. Berndt et al. Nature Communications
- Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial
- (2016) Richard Greil et al. Lancet Haematology
- Insecticide exposure and farm history in relation to risk of lymphomas and leukemias in the Women's Health Initiative observational study cohort
- (2015) Leah H. Schinasi et al. ANNALS OF EPIDEMIOLOGY
- Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) B. Eichhorst et al. ANNALS OF ONCOLOGY
- No evidence of transmission of chronic lymphocytic leukemia through blood transfusion
- (2015) H. Hjalgrim et al. BLOOD
- Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial
- (2015) Jennifer R. Brown et al. BLOOD
- PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia
- (2015) F. McClanahan et al. BLOOD
- Familial predisposition and genetic risk factors for lymphoma
- (2015) J. R. Cerhan et al. BLOOD
- Eliminating minimal residual disease as a therapeutic end point: working toward cure for patients with CLL
- (2015) P. A. Thompson et al. BLOOD
- Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL
- (2015) R. Guieze et al. BLOOD
- Perturbation of the normal immune system in patients with CLL
- (2015) F. Forconi et al. BLOOD
- A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies
- (2015) H. S. Walter et al. BLOOD
- Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia
- (2015) D. Rossi et al. BLOOD
- Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification
- (2015) P. Strati et al. BLOOD
- Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia
- (2015) P. A. Thompson et al. BLOOD
- Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial
- (2015) K. Fischer et al. BLOOD
- Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
- (2015) V. Ljungstrom et al. BLOOD
- Mycophenolate mofetil therapy for severe immune thrombocytopenia
- (2015) Alice Taylor et al. BRITISH JOURNAL OF HAEMATOLOGY
- Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens
- (2015) Philip A. Thompson et al. CANCER
- Racial differences in three major NHL subtypes: Descriptive epidemiology
- (2015) Yang Li et al. Cancer Epidemiology
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib - Findings from an Investigator-Initiated Phase II Study
- (2015) C. U. Niemann et al. CLINICAL CANCER RESEARCH
- Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia
- (2015) F. Cervantes-Gomez et al. CLINICAL CANCER RESEARCH
- Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century
- (2015) Dianne Pulte et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation
- (2015) Jian Yu et al. JOURNAL OF CLINICAL INVESTIGATION
- Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial
- (2015) Peter Hillmen et al. LANCET
- Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome
- (2015) F P Tambaro et al. LEUKEMIA
- Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease
- (2015) F R Mauro et al. LEUKEMIA
- Management of adverse events associated with idelalisib treatment: expert panel opinion
- (2015) Steven E. Coutré et al. LEUKEMIA & LYMPHOMA
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
- (2015) Jan Krönke et al. NATURE
- Non-coding recurrent mutations in chronic lymphocytic leukaemia
- (2015) Xose S. Puente et al. NATURE
- Mutations driving CLL and their evolution in progression and relapse
- (2015) Dan A. Landau et al. NATURE
- Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
- (2015) Jan A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations
- (2015) Drew C. Deniger et al. PLoS One
- TCL1targetingmiR-3676is codeleted with tumor protein p53 in chronic lymphocytic leukemia
- (2015) Veronica Balatti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- (2015) David L. Porter et al. Science Translational Medicine
- Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL
- (2015) Filomena De Falco et al. Oncotarget
- Autoimmune cytopenias in chronic lymphocytic leukemia
- (2014) Carlo Visco et al. AMERICAN JOURNAL OF HEMATOLOGY
- MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia
- (2014) B. Cui et al. BLOOD
- Somatic mutation as a mechanism of Wnt/ -catenin pathway activation in CLL
- (2014) L. Wang et al. BLOOD
- Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia
- (2014) N. Pflug et al. BLOOD
- Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21WAF1/Cip1-dependent mechanism independent of functional p53
- (2014) J.-F. Fecteau et al. BLOOD
- Locally Disordered Methylation Forms the Basis of Intratumor Methylome Variation in Chronic Lymphocytic Leukemia
- (2014) Dan A. Landau et al. CANCER CELL
- New Strategies in Chronic Lymphocytic Leukemia: Shifting Treatment Paradigms
- (2014) F. T. Awan et al. CLINICAL CANCER RESEARCH
- The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy
- (2014) G. Packham et al. HAEMATOLOGICA
- Antibody Deficiency Secondary to Chronic Lymphocytic Leukemia: Should Patients be Treated with Prophylactic Replacement Immunoglobulin?
- (2014) Fatima Dhalla et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Lenalidomide and Rituximab for the Initial Treatment of Patients With Chronic Lymphocytic Leukemia: A Multicenter Clinical-Translational Study From the Chronic Lymphocytic Leukemia Research Consortium
- (2014) Danelle F. James et al. JOURNAL OF CLINICAL ONCOLOGY
- CD49d Is the Strongest Flow Cytometry–Based Predictor of Overall Survival in Chronic Lymphocytic Leukemia
- (2014) Pietro Bulian et al. JOURNAL OF CLINICAL ONCOLOGY
- Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia
- (2014) A Veronese et al. LEUKEMIA
- The impact of SF3B1 mutations in CLL on the DNA-damage response
- (2014) G D te Raa et al. LEUKEMIA
- A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact
- (2014) A C Queirós et al. LEUKEMIA
- The impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive Surveillance, Epidemiology, and End Results analysis in the modern era
- (2014) Chadi Nabhan et al. LEUKEMIA & LYMPHOMA
- Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
- (2014) Jennifer A. Woyach et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
- (2014) Valentin Goede et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
- (2014) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acquired Initiating Mutations in Early Hematopoietic Cells of CLL Patients
- (2014) F. Damm et al. Cancer Discovery
- Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function
- (2013) V. Coelho et al. BLOOD
- Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
- (2013) E. Chigrinova et al. BLOOD
- A role for IRF4 in the development of CLL
- (2013) V. Shukla et al. BLOOD
- TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial
- (2013) P. Dreger et al. BLOOD
- Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
- (2013) M. Hudecek et al. CLINICAL CANCER RESEARCH
- Prophylaxis against hepatitis B reactivation among patients with lymphoma receiving rituximab
- (2013) Joseph Adrian Lumawig Buensalido et al. Expert Review of Anti-Infective Therapy
- Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia
- (2013) P. G. Ferreira et al. GENOME RESEARCH
- Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome
- (2013) Giulia Fabbri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The impact of Agent Orange exposure on presentation and prognosis of patients with chronic lymphocytic leukemia
- (2013) Lisa M. Baumann Kreuziger et al. LEUKEMIA & LYMPHOMA
- MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia
- (2013) Marek Mraz et al. LEUKEMIA & LYMPHOMA
- Cell of origin associated classification of B-cell malignancies by gene signatures of the normal B-cell hierarchy
- (2013) Hans Erik Johnsen et al. LEUKEMIA & LYMPHOMA
- Fludarabine: A review of the clear benefits and potential harms
- (2013) Joshua Lukenbill et al. LEUKEMIA RESEARCH
- Charting a dynamic DNA methylation landscape of the human genome
- (2013) Michael J. Ziller et al. NATURE
- A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia
- (2013) Helen E Speedy et al. NATURE GENETICS
- Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
- (2013) Sonja I Berndt et al. NATURE GENETICS
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- The Incidence of Leukemia, Lymphoma and Multiple Myeloma among Atomic Bomb Survivors: 1950–2001
- (2013) Wan-Ling Hsu et al. RADIATION RESEARCH
- Evolution of DNA Methylation Is Linked to Genetic Aberrations in Chronic Lymphocytic Leukemia
- (2013) C. C. Oakes et al. Cancer Discovery
- Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics
- (2013) Dan A Landau et al. Genome Medicine
- Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
- (2012) A. Agathangelidis et al. BLOOD
- Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
- (2012) D. Rossi et al. BLOOD
- The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
- (2012) M. F. M. de Rooij et al. BLOOD
- Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer
- (2012) A. G. Ramsay et al. BLOOD
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interactions between bone marrow stromal microenvironment and B-chronic lymphocytic leukemia cells: Any role for Notch, Wnt and Hh signaling pathways?
- (2012) Paul Faustin Seke Etet et al. CELLULAR SIGNALLING
- Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia
- (2012) Lirong Pei et al. Epigenetics
- Bendamustine for treatment of chronic lymphocytic leukemia
- (2012) Julie Elizabeth Chang et al. EXPERT OPINION ON PHARMACOTHERAPY
- Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
- (2012) Xavier C. Badoux et al. JOURNAL OF CLINICAL ONCOLOGY
- 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
- (2012) N Cahill et al. LEUKEMIA
- NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome
- (2012) N Villamor et al. LEUKEMIA
- Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function
- (2012) D J DiLillo et al. LEUKEMIA
- Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
- (2012) Marcus Dühren-von Minden et al. NATURE
- Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia
- (2012) Marta Kulis et al. NATURE GENETICS
- Diagnostic Usefulness and Prognostic Impact of CD200 Expression in Lymphoid Malignancies and Plasma Cell Myeloma
- (2011) Daisy Alapat et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL
- (2011) S. Decker et al. BLOOD
- Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia
- (2011) X. C. Badoux et al. BLOOD
- The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation
- (2011) D. Rossi et al. BLOOD
- The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
- (2011) S. Ponader et al. BLOOD
- Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment
- (2011) Kate Hodgson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature
- (2011) Bruno Bockorny et al. BRITISH JOURNAL OF HAEMATOLOGY
- Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia
- (2011) Issa F. Khouri et al. CANCER
- The Pax-5 Gene: A Pluripotent Regulator of B-cell Differentiation and Cancer Disease
- (2011) P. O'Brien et al. CANCER RESEARCH
- Treating chronic lymphocytic leukemia with thalidomide and lenalidomide
- (2011) Krzysztof Giannopoulos et al. EXPERT OPINION ON PHARMACOTHERAPY
- Monophosphorylation of CD79a and CD79b ITAM Motifs Initiates a SHIP-1 Phosphatase-Mediated Inhibitory Signaling Cascade Required for B Cell Anergy
- (2011) Shannon K. O'Neill et al. IMMUNITY
- Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia
- (2011) Muller Fabbri JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Analysis of the chronic lymphocytic leukemia coding genome: role ofNOTCH1mutational activation
- (2011) Giulia Fabbri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1
- (2011) P Liu et al. LEUKEMIA
- Unknown
- (2011) Carlo Calissano et al. MOLECULAR MEDICINE
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
- (2011) Víctor Quesada et al. NATURE GENETICS
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
- (2011) Lili Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties
- (2010) T. Tadmor et al. ANNALS OF ONCOLOGY
- The lymph node microenvironment promotes B-cell receptor signaling, NF- B activation, and tumor proliferation in chronic lymphocytic leukemia
- (2010) Y. Herishanu et al. BLOOD
- Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL
- (2010) S. L. Slager et al. BLOOD
- Second malignancies in B-cell chronic lymphocytic leukaemia: possible association with human papilloma virus
- (2010) Joseph M. Flynn et al. BRITISH JOURNAL OF HAEMATOLOGY
- The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia
- (2010) Ulf Klein et al. CANCER CELL
- Molecular underpinning of B-cell anergy
- (2010) Yuval Yarkoni et al. IMMUNOLOGICAL REVIEWS
- Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
- (2010) William G. Wierda et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management
- (2010) T D Shanafelt et al. LEUKEMIA
- Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk
- (2010) Dalemari Crowther-Swanepoel et al. NATURE GENETICS
- Elucidating the CXCL12/CXCR4 Signaling Network in Chronic Lymphocytic Leukemia through Phosphoproteomics Analysis
- (2010) Morgan O'Hayre et al. PLoS One
- B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406
- (2009) M. P. Quiroga et al. BLOOD
- Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
- (2009) J. W. Friedberg et al. BLOOD
- Down-regulation of CXCR4 and CD62L in Chronic Lymphocytic Leukemia Cells Is Triggered by B-Cell Receptor Ligation and Associated with Progressive Disease
- (2009) A. Vlad et al. CANCER RESEARCH
- Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome
- (2009) D. Rossi et al. CLINICAL CANCER RESEARCH
- A comprehensive catalogue of somatic mutations from a human cancer genome
- (2009) Erin D. Pleasance et al. NATURE
- Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection
- (2008) E. M. Ghia et al. BLOOD
- FMC7 is an epitope of CD20
- (2008) J. P. Deans et al. BLOOD
- Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia
- (2008) A. Ferrajoli et al. BLOOD
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia
- (2008) J E Castro et al. LEUKEMIA
- A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia
- (2008) Maria Chiara Di Bernardo et al. NATURE GENETICS
- Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia
- (2008) Andy C. Rawstron et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a
- (2008) T. Fukuda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started